(Reuters) – Walgreens Boots Alliance (NASDAQ:) agreed to pay $106.8 million to settle fees it billed the U.S. authorities for prescriptions that have been by no means disbursed, the Division of Justice stated on Friday.
The Justice Division stated that from 2009 to 2020, Walgreens submitted false claims for cost to Medicare, Medicaid and different federal well being care packages for prescriptions it processed however which have been by no means picked up.
March 1, 2026 Update: Our CEO, Mark Brookshire, had the great pleasure last week to interview David Gardner, co-founder of...
Your warehouse wasn’t built to store returns. When 11-25% of your warehouse space sits occupied by returns and excess inventory,...
If you’ve ever felt frustrated by slow-loading finance websites cluttered with ads and pop-ups, you’re not alone. StockAnalysis.com has quietly...
“The rich are getting richer,” Arnott said. “Vastly so. But, it’s never the same people for long.” The name Rockefeller,...
Janus Henderson Investors exists to help clients achieve their long-term financial goals. Formed in 2017 from the merger between Janus...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
